## **Core Concept**
The question tests the knowledge of specific autoantibodies associated with various autoimmune diseases, particularly those related to connective tissue disorders. Autoantibodies against topoisomerase I (also known as Scl-70) are highly specific for a particular condition. Topoisomerase I is an enzyme involved in DNA replication and transcription.

## **Why the Correct Answer is Right**
The correct answer, **C.**, corresponds to anti-topoisomerase I, which is a marker for **Systemic Sclerosis (scleroderma)**, particularly for the diffuse form of the disease. Systemic sclerosis is characterized by fibrosis of the skin and internal organs, vascular alterations, and autoantibody production. Anti-topoisomerase I (Scl-70) antibodies are among the diagnostic criteria and are associated with a more severe and diffuse form of systemic sclerosis.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because it does not correspond to anti-topoisomerase I.
- **Option B:** This option is incorrect as it does not represent the correct association with anti-topoisomerase I.
- **Option D:** This option is incorrect because it is not linked to anti-topoisomerase I or the condition for which it is a marker.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that **anti-topoisomerase I (Scl-70) antibodies** are highly specific for **diffuse systemic sclerosis** and are associated with a worse prognosis and more severe organ involvement. Their presence can guide the diagnosis and management of patients with systemic sclerosis.

## **Correct Answer:** **C.**